Bente E. Arbo
GE Healthcare
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bente E. Arbo.
Journal of the American College of Cardiology | 2008
Susanne W.M. van den Borne; Satoshi Isobe; Johan Verjans; Artiom Petrov; Dagfinn Løvhaug; Peng Li; H. Reinier Zandbergen; Youping Ni; Peter M. Frederik; Jun Zhou; Bente E. Arbo; Astri Rogstad; Alan Cuthbertson; Salah Chettibi; Chris Reutelingsperger; W. Matthijs Blankesteijn; Jos F.M. Smits; Mat J.A.P. Daemen; Faiez Zannad; Mani A. Vannan; Navneet Narula; Bertram Pitt; Leonard Hofstra; Jagat Narula
OBJECTIVES The purpose of this study was to evaluate interstitial alterations in myocardial remodeling using a radiolabeled Cy5.5-RGD imaging peptide (CRIP) that targets myofibroblasts. BACKGROUND Collagen deposition and interstitial fibrosis contribute to cardiac remodeling and heart failure after myocardial infarction (MI). Evaluation of myofibroblastic proliferation should provide indirect evidence of the extent of fibrosis. METHODS Of 46 Swiss-Webster mice, MI was induced in 41 by coronary artery occlusion, and 5 were unmanipulated. Of the 41 mice, 6, 6, and 5 received intravenous technetium-99m labeled CRIP for micro-single-photon emission computed tomography imaging 2, 4, and 12 weeks after MI, respectively; 8 received captopril or captopril with losartan up to 4 weeks after MI. Scrambled CRIP was used 4 weeks after MI in 6 mice; the remaining 10 of 46 mice received unradiolabeled CRIP for histologic characterization. RESULTS Maximum CRIP uptake was observed in the infarct area; quantitative uptake (percent injected dose/g) was highest at 2 weeks (2.75 +/- 0.46%), followed by 4 (2.26 +/- 0.09%) and 12 (1.74 +/- 0.24%) weeks compared with that in unmanipulated mice (0.59 +/- 0.19%). Uptake was higher at 12 weeks in the remote areas. CRIP uptake was histologically traced to myofibroblasts. Captopril alone (1.78 +/- 0.31%) and with losartan (1.13 +/- 0.28%) significantly reduced tracer uptake; scrambled CRIP uptake in infarct area (0.74 +/- 0.17%) was similar to CRIP uptake in normal myocardium. CONCLUSIONS Radiolabeled CRIP allows for noninvasive visualization of interstitial alterations during cardiac remodeling, and is responsive to antiangiotensin treatment. If proven clinically feasible, such a strategy would help identify post-MI patients likely to develop heart failure.
Molecular Imaging and Biology | 2012
Sven Macholl; Matthew Morrison; Peter Iveson; Bente E. Arbo; Oleg A. Andreev; Yana K. Reshetnyak; Donald M. Engelman; Edvin Wilhelm Johannesen
PurposeA novel molecular imaging agent has been developed recently, which stains tissues of low extracellular pH [pH (low) insertion peptide, pHLIP®]. A pH-dependent process of peptide folding and insertion into cell membranes has been found in vitro. Targeting of acidic solid tumours has been demonstrated in vivo using fluorescence and PET labels. Here, we present proof of feasibility studies of pHLIP with a single-photon emission computed tomography (SPECT) label, 99mTc-AH114567, with focus on preclinical efficacy and imageability.ProceduresLewis lung carcinoma, lymph node carcinoma of the prostate and prostate adenocarcinoma tumour xenografts were grown in mice and characterised by the angiogenesis marker 99mTc-NC100692 and by extracellular pH measurements with 31P-MRS of 3-aminopropyl phosphonate. Biodistribution was assessed and CT/SPECT imaging performed. Oral administration of bicarbonate served as control.Results and ConclusionTc-AH114567 can be obtained via a robust synthesis with good radiolabelling profile and improved formulation. The tracer retains the pH-dependent ability to insert into membranes and to target tumours with similar pharmacokinetics and efficacy that had been demonstrated earlier for pHLIP with optical or 64Cu PET labels. Despite the inherent challenges of SPECT compared to optical and PET imaging, e.g., in terms of lower sensitivity, 99mTc-AH114567 shows adequate image quality and contrast. The main development need for transitioning SPECT labelled pHLIP into the clinic is more rapid background signal reduction, which will be the focus of a subsequent optimisation study.
Ultrasound in Medicine and Biology | 2011
Astrid Hilde Myrset; Hege Fjerdingstad; Ragnar Bendiksen; Bente E. Arbo; Roger M. Bjerke; John Henrik Johansen; Mari Ann Kulseth; Roald Skurtveit
Targeted ultrasound (US) contrast agents represent, because of their size (1 to 5 μm), a unique class of diagnostic imaging agents enabling true vascular imaging of conditions like inflammation and tumor angiogenesis. The objective of this study was to develop technology for preparing targeted microbubbles with binding and acoustic properties compatible with diagnostic use. Phosphatidylcholine (PC) was shown to represent the most favorable wall material. Various thiolated peptide binders were effectively conjugated to PC-based microbubbles containing maleimide functionalized lipids (95:5) without the need for biotin-streptavidin or antibody technology. By optimizing the technology, specific targeting of the inflammatory target E-selectin and the angiogenic target VEGFR2 in the presence of 100% serum was achieved. Increased phospholipid chain length from 18 carbons to 22 carbons improved the stability of the microbubbles during US exposure, without compromising binding or acoustic properties.
Archive | 2006
Benedicte Guilbert; Sue Champion; Alexander Mark Gibson; Sally-Anne Ricketts; Michelle Avory; Bente E. Arbo
Archive | 2007
Sally-Ann Ricketts; Alexander Jackson; Bente E. Arbo; Michelle Avory
Archive | 2005
Alan Cuthbertson; Bente E. Arbo
Archive | 2005
Alan Cuthbertson; Bente E. Arbo
Archive | 2012
Sven Macholl; Matthew Morrison; Peter Iveson; Bente E. Arbo; Oleg A. Andreev; Yana K. Reshetnyak; Donald M. Engelman; Edvin Wilhelm Johannesen
The Journal of Nuclear Medicine | 2011
Roger M. Bjerke; Anne-Marie Hvoslef; Bente E. Arbo; Stein Waagene; Gerd Torgersen; Astri Rogstad; Grete Mørk Kindberg; Edvin Wilhelm Johannesen
Archive | 2006
Benedicte Guilbert; Sue Champion; Alexander Mark Gibson; Sally-Anne Ricketts; Michelle Avory; Bente E. Arbo